As of 2025-09-16, the Relative Valuation of Kaleido Biosciences Inc (KLDO) is (114,259.64) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.29 USD, the upside of Kaleido Biosciences Inc based on Relative Valuation is -39399975.1%.
The range of the Relative Valuation is (111,188.14) - (115,365.38) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.2x - 18.8x | 18.6x |
| Forward P/E multiples | 18.1x - 19.3x | 18.6x |
| Fair Price | (111,188.14) - (115,365.38) | (114,259.64) |
| Upside | -38340838.7% - -39781264.2% | -39399975.1% |
| Date | P/E |
| 2025-08-29 | -0.00 |
| 2025-08-28 | -0.00 |
| 2025-08-22 | -0.00 |
| 2025-08-21 | -0.00 |
| 2025-08-08 | 0.00 |
| 2025-08-07 | -0.00 |
| 2025-08-06 | -0.00 |
| 2025-08-04 | -0.00 |
| 2025-08-01 | -0.00 |
| 2025-07-31 | -0.00 |
| 2025-07-30 | -0.00 |
| 2025-07-02 | 0.00 |
| 2025-06-30 | -0.00 |
| 2025-06-24 | -0.00 |
| 2025-06-23 | -0.00 |
| 2025-06-20 | -0.00 |
| 2025-06-18 | -0.00 |
| 2025-06-16 | -0.00 |
| 2025-06-13 | -0.00 |